π΄ IMPORTANT: Read This Before Proceeding With Dosing
Go to the Prep & Injection Guide for proper reconstitution, syringe sizing, and injection protocols. Mistakes here can compromise your research.
π Click here to read the Prep & Injection Guide
Cagrilinitide (or βCagriβ) is a long-acting, lipidated, albumin-binding amylin agonist that targets both amylin and calcitonin receptors. It is used in the treatment of obesity, either on its own or in combination with GLP-1 receptor agonists. Amylin is co-secreted with insulin from pancreatic beta cells and regulates appetite, satiety, gastric emptying, and glucose control.
Combining Cagrilinitide with a GLP-1 like Semaglutide has a synergistic effect, amplifying weight loss beyond what either peptide achieves independently. Other benefits include improved circulation, reduced blood pressure, enhanced bone-building activity, and vasodilation.
Outcomes
- 6β10% body weight loss at 26 weeks (Cagrilinitide alone)
- 23β24.4% body weight loss at 68 weeks (combined with Semaglutide)
- Synergistic effect: up to 8% more weight loss vs. Semaglutide alone
Possible Side Effects
- Injection site reaction (redness, swelling, itching, hives)
- Nausea
- Vomiting
- Constipation
- Fatigue
- Headache
- Diarrhea
- Heartburn
- Gallbladder stones (rare)
Dosing
CAGRILINITIDE: 10MG
Mix with 2mL (200 units) of BAC water
Subcutaneous Administration
16-week cycle followed by a 4β6 week washout period
- Week 1: 8 units (400mcg)
- Weeks 2 & 3: 15 units (750mcg)
- Weeks 4 & 5: 24 units (1.2mg)
- Weeks 6 & 7: 34 units (1.7mg)
- Weeks 8 & 9: 44 units (2.2mg)
- Weeks 10-16: 54 units (2.7mg)
Important Notes
- Always dose on the same day each week
- Ensure adequate hydration throughout the cycle
- Do not exceed 16 consecutive weeks of use
- Anti-Cagri antibodies may form with extended use (46β73% of users)
Stacking Suggestions
- Semaglutide or Tirzepatide β Boosts appetite suppression and fat loss via GLP-1 synergy
- Tesofensine β Enhances energy expenditure and thermogenesis
- L-Carnitine β Supports fat metabolism and energy conversion
- AOD-9604 β Encourages lipolysis and body fat reduction without affecting blood sugar